(19)
(11) EP 1 656 367 A1

(12)

(43) Date of publication:
17.05.2006 Bulletin 2006/20

(21) Application number: 04739898.7

(22) Date of filing: 14.06.2004
(51) International Patent Classification (IPC): 
C07D 401/14(1990.01)
A61K 31/538(2000.01)
C07D 413/14(1990.01)
A61P 13/12(2000.01)
(86) International application number:
PCT/EP2004/006427
(87) International publication number:
WO 2004/111036 (23.12.2004 Gazette 2004/52)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
Designated Extension States:
HR LT LV

(30) Priority: 16.06.2003 GB 0313915

(71) Applicant: SMITHKLINE BEECHAM CORPORATION
Philadelphia, Pennsylvania 19101 (US)

(72) Inventors:
  • DODIC, Nerina, Laboratoire GlaxoSmithKline
    F-91951 Les Ulis (FR)
  • DONCHE, Frederic, Laboratoire GlaxoSmithKline
    F-91951 Les Ulis (FR)
  • GELLIBERT, Francoise Jeanne, Lab. GlaxoSmithKline
    F-91951 Les Ulis (FR)

(74) Representative: Sardharwala, Fatema Elyasali 
GlaxoSmithKline Corporate Intellectual Property 980 Great West Road
GB-Brentford, Middlesex TW8 9GS
GB-Brentford, Middlesex TW8 9GS (GB)

   


(54) 4- (HETEROCYCLYL- FUSED PHENYL)- 3- (PHENYL OR PYRID -2- YL) PYRAZOLES AS INHIBITORS OF THE ALK-5- RECEPTOR